Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impaired myocardial work in heart failure with improved ejection fraction: A post hoc analysis from the CATHEDRAL-HF trial.

International journal of cardiology·2025
Same author

Sacubitril-Valsartan vs Enalapril in Heart Failure Due to Chagas Disease: Primary Results of ANSWER-HF Randomized Trial.

Journal of the American College of Cardiology·2025
Same author

Brazilian Multicenter Registry of Alcohol Septal Ablation for Patients with Symptomatic Hypertrophic Obstructive Cardiomyopathy - BRASA Registry.

Arquivos brasileiros de cardiologia·2025
Same author

Methotrexate Improves Left Ventricle Systolic and Diastolic Function in Induced Takotsubo Myocardiopathy Rats.

Journal of cardiovascular pharmacology·2025
Same author

Acute Heart Failure in Patients with Chagas Cardiomyopathy: Results of the I Brazilian Heart Failure Registry (BREATHE).

Arquivos brasileiros de cardiologia·2025
Same author

Prognostic Value of Nonsustained Ventricular Tachycardia in Hypertrophic Cardiomyopathy in a Brazilian Cohort: Comparison with World Literature.

Arquivos brasileiros de cardiologia·2025
Same journal

Eugene Braunwald: Lessons and Stories from the Father of Modern Cardiology.

Arquivos brasileiros de cardiologia·2026
Same journal

Catheter Ablation in the Brazilian Unified Health System (SUS): Between Consolidated Evidence and Limited Access.

Arquivos brasileiros de cardiologia·2026
Same journal

Impact of Population Aging on Cardiovascular Disease Prevalence in the Macroregions of Brazil: Forecasts to 2050.

Arquivos brasileiros de cardiologia·2026
Same journal

Premature Atrial Contractions Originating from the Inferior Vena Cava: A Rare Arrhythmogenic Source Amenable to Ablation.

Arquivos brasileiros de cardiologia·2026
Same journal

Radiofrequency Ablation for Treating Cardiac Arrhythmias in Brazil: Status in the Unified Health System.

Arquivos brasileiros de cardiologia·2026
Same journal

Does HFpEF Really Exist? From Mimics to Misclassification in Clinical PracticeReply.

Arquivos brasileiros de cardiologia·2026
See all related articles

Related Experiment Video

Updated: May 29, 2026

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
14:39

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples

Published on: April 21, 2014

Noncompaction cardiomyopathy: a current view.

Leonardo Vieira da Rosa1, Vera Maria Cury Salemi, Leonardo Machado Alexandre

  • 1Instituto do Coração, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil. vieira27130@yahoo.com.br

Arquivos Brasileiros De Cardiologia
|September 7, 2011
PubMed
Summary
This summary is machine-generated.

Isolated non-compaction cardiomyopathy, a rare heart muscle disease, arises during embryonic development. This review highlights advanced imaging techniques beyond echocardiography for diagnosing this condition in adults.

More Related Videos

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Related Experiment Videos

Last Updated: May 29, 2026

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
14:39

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples

Published on: April 21, 2014

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Area of Science:

  • Cardiology
  • Developmental Biology

Background:

  • Isolated non-compaction cardiomyopathy is a rare congenital heart defect.
  • It results from impaired myocardial compaction during embryonic development.
  • Characterized by prominent trabeculations and deep recesses, it affects adults without other heart conditions.

Purpose of the Study:

  • To review diagnostic alternatives for isolated non-compaction cardiomyopathy.
  • To address diagnostic delays caused by echocardiography limitations and disease rarity.

Main Methods:

  • Literature review of diagnostic imaging techniques for non-compaction cardiomyopathy.
  • Focus on Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and left ventriculography.

Main Results:

  • Echocardiography, while common, has limitations in diagnosing this condition.
  • MRI, CT, and left ventriculography offer valuable diagnostic alternatives.
  • These advanced techniques aid in identifying characteristic myocardial features.

Conclusions:

  • Diagnosis of isolated non-compaction cardiomyopathy can be challenging.
  • Advanced imaging modalities like MRI and CT are crucial for accurate diagnosis.
  • Increased awareness and utilization of these techniques can improve patient outcomes.